{"id":55005,"date":"2023-03-20T20:03:35","date_gmt":"2023-03-20T19:03:35","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\/"},"modified":"2023-03-20T20:03:35","modified_gmt":"2023-03-20T19:03:35","slug":"techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\/","title":{"rendered":"Techdow USA Announces FDA Approval of Generic Lovenox\u00ae, (Enoxaparin Sodium \u2013 Preservative Free) In Prefilled Syringes"},"content":{"rendered":"<div>\n<p>LANGHORNE, Pa.&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/hashtag\/Enoxaparin?src=hash\" target=\"_blank\" rel=\"noopener\">#Enoxaparin<\/a>&#8211;Techdow USA Inc. (\u201cTechdow USA\u201d), a growing market leader and vertically integrated generic injectables company, today announced the FDA approval of Enoxaparin Sodium (Preservative Free) in Prefilled Syringes for the U.S. market.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230317005370\/en\/1741601\/5\/Techdow-Logo-CMYK.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230317005370\/en\/1741601\/21\/Techdow-Logo-CMYK.jpg\"><\/a><\/p>\n<p>\n\u201cTechdow USA is excited to bring this critical product to institutions, retail and other networks in need of a safe, affordable and reliable source of Enoxaparin,\u201d said Darren Alkins, Chief Executive Officer of Techdow USA. \u201cAs a vertically integrated company in this complex environment with difficult to source raw material and state-of-the-art prefilled syringe manufacturing, our U.S. and global networks will help ensure reliable Enoxaparin supply, while offering competitive pricing. Techdow USA will be a long-term reliable resource to the marketplace.\u201d\n<\/p>\n<p>\nThe launch of Enoxaparin will compliment Techdow USA\u2019s existing Heparin Sodium injection business, which was successfully launched in 2022.\n<\/p>\n<p>\nEnoxaparin Sodium (Preservative Free) Prefilled Syringes had US brand and generic sales of approximately $550 million, according to IQVIA Health for the 12 months ending December, 2022.\n<\/p>\n<p>\nTechdow USA is among the fastest growing companies in the US generic pharmaceutical industry specializing in the sale of generic injectable pharmaceuticals and continues to work to expand their product portfolio and pipeline to better serve patient and customer needs.\n<\/p>\n<p>\n<b>To report SUSPECTED ADVERSE REACTIONS, contact Hepalink USA, Inc.\/Techdow USA, Inc. at 1-888-355-1375 or FDA at 1-800-FDA-1088 or <\/b><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.fda.gov%2Fmedwatch&amp;esheet=53363964&amp;newsitemid=20230317005370&amp;lan=en-US&amp;anchor=www.fda.gov%2Fmedwatch&amp;index=1&amp;md5=b796ea1e6ba6fb88a9fc45bf22af5d99\" rel=\"nofollow noopener\" shape=\"rect\"><b>www.fda.gov\/medwatch<\/b><\/a><b>.<\/b>\n<\/p>\n<p>\nFor more information, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.techdowusa.com&amp;esheet=53363964&amp;newsitemid=20230317005370&amp;lan=en-US&amp;anchor=www.techdowusa.com&amp;index=2&amp;md5=d730798acf7ccfb2e7164e095b766a0a\" rel=\"nofollow noopener\" shape=\"rect\">www.techdowusa.com<\/a>.\n<\/p>\n<p>\n<i>*Lovenox\u00ae is a registered trademark of Sanofi-Aventis U.S. LLC<\/i>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nJonathan Mordh<br \/>\n<br \/>(608) 807-8905<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;a&#x69;l&#x74;o&#x3a;J&#x6f;n&#x61;t&#x68;&#97;&#x6e;&#46;&#x4d;&#111;&#x72;&#100;&#x68;&#64;&#x54;&#101;&#x63;&#104;d&#x6f;w&#x55;S&#x41;&#46;&#x63;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">J&#111;&#110;&#97;&#x74;&#x68;&#x61;n&#46;&#77;&#111;&#x72;&#x64;&#x68;&#x40;Te&#99;&#104;&#x64;&#x6f;&#x77;&#x55;S&#65;&#46;&#99;&#x6f;&#x6d;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>LANGHORNE, Pa.&#8211;(BUSINESS WIRE)&#8211;#Enoxaparin&#8211;Techdow USA Inc. (\u201cTechdow USA\u201d), a growing market leader and vertically integrated generic injectables company, today announced the FDA approval of Enoxaparin Sodium (Preservative Free) in Prefilled Syringes for the U.S. market. \u201cTechdow USA is excited to bring this critical product to institutions, retail and other networks in need of a safe, affordable &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55005","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Techdow USA Announces FDA Approval of Generic Lovenox\u00ae, (Enoxaparin Sodium \u2013 Preservative Free) In Prefilled Syringes - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Techdow USA Announces FDA Approval of Generic Lovenox\u00ae, (Enoxaparin Sodium \u2013 Preservative Free) In Prefilled Syringes - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LANGHORNE, Pa.&#8211;(BUSINESS WIRE)&#8211;#Enoxaparin&#8211;Techdow USA Inc. (\u201cTechdow USA\u201d), a growing market leader and vertically integrated generic injectables company, today announced the FDA approval of Enoxaparin Sodium (Preservative Free) in Prefilled Syringes for the U.S. market. \u201cTechdow USA is excited to bring this critical product to institutions, retail and other networks in need of a safe, affordable ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-20T19:03:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230317005370\/en\/1741601\/21\/Techdow-Logo-CMYK.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Techdow USA Announces FDA Approval of Generic Lovenox\u00ae, (Enoxaparin Sodium \u2013 Preservative Free) In Prefilled Syringes\",\"datePublished\":\"2023-03-20T19:03:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\\\/\"},\"wordCount\":271,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230317005370\\\/en\\\/1741601\\\/21\\\/Techdow-Logo-CMYK.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\\\/\",\"name\":\"Techdow USA Announces FDA Approval of Generic Lovenox\u00ae, (Enoxaparin Sodium \u2013 Preservative Free) In Prefilled Syringes - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230317005370\\\/en\\\/1741601\\\/21\\\/Techdow-Logo-CMYK.jpg\",\"datePublished\":\"2023-03-20T19:03:35+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230317005370\\\/en\\\/1741601\\\/21\\\/Techdow-Logo-CMYK.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230317005370\\\/en\\\/1741601\\\/21\\\/Techdow-Logo-CMYK.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Techdow USA Announces FDA Approval of Generic Lovenox\u00ae, (Enoxaparin Sodium \u2013 Preservative Free) In Prefilled Syringes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Techdow USA Announces FDA Approval of Generic Lovenox\u00ae, (Enoxaparin Sodium \u2013 Preservative Free) In Prefilled Syringes - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\/","og_locale":"en_US","og_type":"article","og_title":"Techdow USA Announces FDA Approval of Generic Lovenox\u00ae, (Enoxaparin Sodium \u2013 Preservative Free) In Prefilled Syringes - Pharma Trend","og_description":"LANGHORNE, Pa.&#8211;(BUSINESS WIRE)&#8211;#Enoxaparin&#8211;Techdow USA Inc. (\u201cTechdow USA\u201d), a growing market leader and vertically integrated generic injectables company, today announced the FDA approval of Enoxaparin Sodium (Preservative Free) in Prefilled Syringes for the U.S. market. \u201cTechdow USA is excited to bring this critical product to institutions, retail and other networks in need of a safe, affordable ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-20T19:03:35+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230317005370\/en\/1741601\/21\/Techdow-Logo-CMYK.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Techdow USA Announces FDA Approval of Generic Lovenox\u00ae, (Enoxaparin Sodium \u2013 Preservative Free) In Prefilled Syringes","datePublished":"2023-03-20T19:03:35+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\/"},"wordCount":271,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230317005370\/en\/1741601\/21\/Techdow-Logo-CMYK.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\/","url":"https:\/\/pharma-trend.com\/en\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\/","name":"Techdow USA Announces FDA Approval of Generic Lovenox\u00ae, (Enoxaparin Sodium \u2013 Preservative Free) In Prefilled Syringes - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230317005370\/en\/1741601\/21\/Techdow-Logo-CMYK.jpg","datePublished":"2023-03-20T19:03:35+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230317005370\/en\/1741601\/21\/Techdow-Logo-CMYK.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230317005370\/en\/1741601\/21\/Techdow-Logo-CMYK.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/techdow-usa-announces-fda-approval-of-generic-lovenox-enoxaparin-sodium-preservative-free-in-prefilled-syringes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Techdow USA Announces FDA Approval of Generic Lovenox\u00ae, (Enoxaparin Sodium \u2013 Preservative Free) In Prefilled Syringes"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55005"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55005\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55005"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55005"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}